Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Acetate as a metabolic booster for glucose-based bioproduction in Escherichia coli

View through CrossRef
Abstract Escherichia coli , a key workhorse in industrial biotechnology, is commonly grown on glucose, which supports rapid growth but leads to acetate overflow, which instead inhibits growth, diverts carbon from the production pathway, and reduces productivity. Recent studies suggest that acetate may also have beneficial effects in glucose-grown E. coli , but its potential in bioprocesses remains unexplored. In this study, we systematically investigated acetate’s impact on bioproduction using a kinetic model of glucose and acetate metabolism in E. coli . The model predicts that acetate can enhance bioproduction in glucose-grown E. coli through three mechanisms: (i) by minimizing acetate overflow, thereby reducing carbon loss, (ii) by increasing acetyl-CoA levels, thereby boosting the biosynthetic flux of acetyl-CoA-derived compounds, and (iii) by promoting biomass accumulation, thus improving overall productivity. We experimentally validated the predictions of the model for mevalonate and 3-hydroxypropionate production, where acetate supplementation increased productivity by 117% and 34%, respectively. Our findings provide a valuable framework for optimizing E. coli -based bioprocesses and highlight acetate’s underutilized potential in biotechnology. By leveraging acetate from waste streams as a metabolic booster, this approach could contribute to more sustainable and environmentally friendly bioprocesses. Highlights - A kinetic model was used for rational optimization of E. coli -based bioprocesses - Acetate can enhance growth and production of acetyl-CoA-derived bioproducts - Model predictions were validated for mevalonate and 3-hydroxypropionate production - Acetate can be used as a metabolic booster for glucose-based bioproduction in E. coli
Title: Acetate as a metabolic booster for glucose-based bioproduction in Escherichia coli
Description:
Abstract Escherichia coli , a key workhorse in industrial biotechnology, is commonly grown on glucose, which supports rapid growth but leads to acetate overflow, which instead inhibits growth, diverts carbon from the production pathway, and reduces productivity.
Recent studies suggest that acetate may also have beneficial effects in glucose-grown E.
coli , but its potential in bioprocesses remains unexplored.
In this study, we systematically investigated acetate’s impact on bioproduction using a kinetic model of glucose and acetate metabolism in E.
coli .
The model predicts that acetate can enhance bioproduction in glucose-grown E.
coli through three mechanisms: (i) by minimizing acetate overflow, thereby reducing carbon loss, (ii) by increasing acetyl-CoA levels, thereby boosting the biosynthetic flux of acetyl-CoA-derived compounds, and (iii) by promoting biomass accumulation, thus improving overall productivity.
We experimentally validated the predictions of the model for mevalonate and 3-hydroxypropionate production, where acetate supplementation increased productivity by 117% and 34%, respectively.
Our findings provide a valuable framework for optimizing E.
coli -based bioprocesses and highlight acetate’s underutilized potential in biotechnology.
By leveraging acetate from waste streams as a metabolic booster, this approach could contribute to more sustainable and environmentally friendly bioprocesses.
Highlights - A kinetic model was used for rational optimization of E.
coli -based bioprocesses - Acetate can enhance growth and production of acetyl-CoA-derived bioproducts - Model predictions were validated for mevalonate and 3-hydroxypropionate production - Acetate can be used as a metabolic booster for glucose-based bioproduction in E.
coli.

Related Results

Cost effectiveness analysis comparing varying booster intervals of vaccination policies to address COVID-19 situation in Thailand, 2023
Cost effectiveness analysis comparing varying booster intervals of vaccination policies to address COVID-19 situation in Thailand, 2023
The COVID-19 booster immunization policy is cost-effective, but evidence on additional booster doses and appropriate strategies is scarce. This research compared the cost-effective...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract Introduction Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Pregnancy and Challenging Transient Anti-GAD65 Positivity: A Case Report with Literature Review
Pregnancy and Challenging Transient Anti-GAD65 Positivity: A Case Report with Literature Review
Abstract Introduction During pregnancy, women may develop blood glucose abnormalities like gestational diabetes mellitus (GDM) or, rarely, type 1 diabetes (T1D), which can lead to ...
Abstract P2-20-01: Safety and Clinical Efficacy of Multiple Booster Inoculations with the E75 Adjuvant Breast Cancer Vaccine
Abstract P2-20-01: Safety and Clinical Efficacy of Multiple Booster Inoculations with the E75 Adjuvant Breast Cancer Vaccine
Abstract Background: We are conducting clinical trials of the HER2/neu E75-peptide+GM-CSF vaccine in clinically disease-free breast cancer patients at high risk for ...
TRANSFORMASI PLASMID YANG MENGANDUNG GEN merB PADA Escherichia coli BL21(DE3)
TRANSFORMASI PLASMID YANG MENGANDUNG GEN merB PADA Escherichia coli BL21(DE3)
ABSTRACTDNA transformation is one of the methods for inserting DNA into bacterial cells. The current transformation method is widely used to transfer plasmids containing genetic ma...
SARS-CoV-2 Neutralizing Antibodies After Bivalent vs. Monovalent Booster
SARS-CoV-2 Neutralizing Antibodies After Bivalent vs. Monovalent Booster
Abstract Bivalent mRNA vaccine boosters expressing Omicron BA.5 spike and ancestral D614G spike were introduced to attempt to boost waning antibody titers and broad...
A Study on Prevalence of Serum Resistant & Sensitive Escherichia Coli in Urinary Tract Infection
A Study on Prevalence of Serum Resistant & Sensitive Escherichia Coli in Urinary Tract Infection
Background: Escherichia coli is the commonest organism causing urinary tract infection in women and children especially in those with uncom- plicated infections. It has been tradit...
Bioinformatics Analysis of Gefitinib or Rapamycin on Inhibiting the Survival of Hela in the Low Glucose and High Lactic Acid Environment
Bioinformatics Analysis of Gefitinib or Rapamycin on Inhibiting the Survival of Hela in the Low Glucose and High Lactic Acid Environment
Objective: To explore on the antitumor effect of gefitinib and rapamycin and possible mechanism in normal glucose and high lactic acid microenvironment. Methods: Hela cells are cul...

Back to Top